Cargando…

Monoplex and multiplex immunoassays: approval, advancements, and alternatives

Immunoassays are a powerful diagnostic tool and are widely used for the quantification of proteins and biomolecules in medical diagnosis and research. Enzyme-linked immunosorbent assay (ELISA) is the most commonly used immunoassay format and allows the detection of biomarkers at a very low concentra...

Descripción completa

Detalles Bibliográficos
Autor principal: Ahsan, Haseeb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605475/
https://www.ncbi.nlm.nih.gov/pubmed/34840549
http://dx.doi.org/10.1007/s00580-021-03302-4
_version_ 1784602187137024000
author Ahsan, Haseeb
author_facet Ahsan, Haseeb
author_sort Ahsan, Haseeb
collection PubMed
description Immunoassays are a powerful diagnostic tool and are widely used for the quantification of proteins and biomolecules in medical diagnosis and research. Enzyme-linked immunosorbent assay (ELISA) is the most commonly used immunoassay format and allows the detection of biomarkers at a very low concentration. The diagnostic platforms such as enzyme immunoassay (EIA), chemiluminescence (CL) assay, polymerase chain reaction (PCR), flow cytometry (FC), and mass spectrometry (MS) have been used to identify molecular biomarkers. However, these diagnostic tools requiring expensive equipment, long testing time, and qualified personnel that is not always available in small local hospitals with limited resources. The lateral flow immunoassay (LFIA) platform was developed for rapidly obtaining laboratory results and to make urgent decisions in emergency medicine, as well as the recently introduced concept of testing at the site of care (point-of-care, POC). The simultaneous measurement of different substances from a single sample called multiplex assays have become increasingly significant for in vitro quantification of multiple analytes in a single sample, thereby minimising cost, time, and volume. In multiplex immunoassays, the ligands are immobilized either in planar format (flat surface) or on microspheres in suspension that binds to target analytes in sample. The multiplex technology has established itself in proteomic networks and pathways, validation of genomic discoveries, and in the development of clinical biomarkers. In the present review article, various types of monoplex/simplex and complex/multiplex immunoassays have been analysed that are increasingly being applied in laboratory medicine. Also, some advantages and disadvantages of these multiplex assays have also been included such as experimental animals, in vitro tests using cell lines and tissue samples, 3-dimensional modelling and bioprinting, in silico tests, organ-on-chip, and computer modelling.
format Online
Article
Text
id pubmed-8605475
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-86054752021-11-22 Monoplex and multiplex immunoassays: approval, advancements, and alternatives Ahsan, Haseeb Comp Clin Path Review Article Immunoassays are a powerful diagnostic tool and are widely used for the quantification of proteins and biomolecules in medical diagnosis and research. Enzyme-linked immunosorbent assay (ELISA) is the most commonly used immunoassay format and allows the detection of biomarkers at a very low concentration. The diagnostic platforms such as enzyme immunoassay (EIA), chemiluminescence (CL) assay, polymerase chain reaction (PCR), flow cytometry (FC), and mass spectrometry (MS) have been used to identify molecular biomarkers. However, these diagnostic tools requiring expensive equipment, long testing time, and qualified personnel that is not always available in small local hospitals with limited resources. The lateral flow immunoassay (LFIA) platform was developed for rapidly obtaining laboratory results and to make urgent decisions in emergency medicine, as well as the recently introduced concept of testing at the site of care (point-of-care, POC). The simultaneous measurement of different substances from a single sample called multiplex assays have become increasingly significant for in vitro quantification of multiple analytes in a single sample, thereby minimising cost, time, and volume. In multiplex immunoassays, the ligands are immobilized either in planar format (flat surface) or on microspheres in suspension that binds to target analytes in sample. The multiplex technology has established itself in proteomic networks and pathways, validation of genomic discoveries, and in the development of clinical biomarkers. In the present review article, various types of monoplex/simplex and complex/multiplex immunoassays have been analysed that are increasingly being applied in laboratory medicine. Also, some advantages and disadvantages of these multiplex assays have also been included such as experimental animals, in vitro tests using cell lines and tissue samples, 3-dimensional modelling and bioprinting, in silico tests, organ-on-chip, and computer modelling. Springer London 2021-11-20 2022 /pmc/articles/PMC8605475/ /pubmed/34840549 http://dx.doi.org/10.1007/s00580-021-03302-4 Text en © The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review Article
Ahsan, Haseeb
Monoplex and multiplex immunoassays: approval, advancements, and alternatives
title Monoplex and multiplex immunoassays: approval, advancements, and alternatives
title_full Monoplex and multiplex immunoassays: approval, advancements, and alternatives
title_fullStr Monoplex and multiplex immunoassays: approval, advancements, and alternatives
title_full_unstemmed Monoplex and multiplex immunoassays: approval, advancements, and alternatives
title_short Monoplex and multiplex immunoassays: approval, advancements, and alternatives
title_sort monoplex and multiplex immunoassays: approval, advancements, and alternatives
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605475/
https://www.ncbi.nlm.nih.gov/pubmed/34840549
http://dx.doi.org/10.1007/s00580-021-03302-4
work_keys_str_mv AT ahsanhaseeb monoplexandmultipleximmunoassaysapprovaladvancementsandalternatives